Page last updated: 2024-09-05

lenalidomide and aee 788

lenalidomide has been researched along with aee 788 in 1 studies

Compound Research Comparison

Studies
(lenalidomide)
Trials
(lenalidomide)
Recent Studies (post-2010)
(lenalidomide)
Studies
(aee 788)
Trials
(aee 788)
Recent Studies (post-2010) (aee 788)
3,5327252,85083334

Protein Interaction Comparison

ProteinTaxonomylenalidomide (IC50)aee 788 (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.002
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)0.004
Tyrosine-protein kinase YesHomo sapiens (human)0.0153
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)0.74
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.059
Receptor tyrosine-protein kinase erbB-3Homo sapiens (human)0.002
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.077
Receptor tyrosine-protein kinase erbB-4Homo sapiens (human)0.002

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

1 other study(ies) available for lenalidomide and aee 788

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013